Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joseph Scheeren currently holds 19,516 shares of Barinthus Biotherapeutics plc. (BRNS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph Scheeren has been a net buyer of BRNS stock. They have purchased $126.3K and sold $0 worth of shares.
Joseph Scheeren's most recent insider trade was on May 10, 2024, when they sold 19,516 shares at $0.00 per share.
Joseph Scheeren serves as Executive at Barinthus Biotherapeutics plc. (BRNS). They have executed 4 insider transactions totaling $126.3K over their tenure at the company.
Joseph Scheeren holds the position of Executive at Barinthus Biotherapeutics plc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Joseph Scheeren has shown a buying trading pattern, with $126.3K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Joseph Scheeren was on May 4, 2021, when they purchased $51.0K worth of VACC shares. This transaction involved 3,000 shares at $17.00 per share.
Joseph Scheeren currently owns 19,516 shares of Barinthus Biotherapeutics plc. (BRNS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joseph Scheeren's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joseph Scheeren has 4 Form 4 filings on record as an insider at Barinthus Biotherapeutics plc..
Set alerts for Joseph Scheeren and 40,000+ other insiders.